Literature DB >> 12673560

Inflammatory pseudotumors of the central nervous system: report of 3 cases and a literature review.

Martin Häusler1, Lars Schaade, Vincent T Ramaekers, Martin Doenges, Gerhard Heimann, Bernd Sellhaus.   

Abstract

Inflammatory pseudotumors (IPs), mostly benign lesions characterized by fibrotic ground tissue and polyclonal mononuclear infiltrate, may affect all organ systems. IPs originating in the central nervous system (IP-CNS) are very rare, and their distinct histopathologic features are poorly characterized. Three otherwise healthy patients (age 8, 15, and 17 years) presented with focal neurologic symptoms (seizures, n = 2; headaches, n = 1), corresponding to a left temporal, left occipital, and left frontal IP, respectively, extending from meningeal structures into brain tissue. After resection, no recurrence was observed in patient 1 during 5 years of follow-up, whereas patient 2 developed a rapidly progressive local recurrence and a second intracerebral lesion despite antiviral, immunosuppressive, antibiotic, and radiation therapy. In patient 3, who also showed local recurrences, sequential histopathologic investigations revealed transformation to a semimalignant fibrohistiocytic tumor. In this patient, anaplastic lymphoma kinase (ALK) expression was also positive, whereas it was negative in patient 1. A detailed literature analysis confirmed that most IP-CNS arise from dural/meningeal structures (n = 34). Intraparenchymatous (n = 7), mixed intraparenchymatous/meningeal (n = 4), and intraventricular lesions (n = 7) or IP extending per continuitatem from intracerebral to extracerebral sites (n = 5) were rare. The recurrence rate was 40% within 2 years in general. It was increased after incomplete resection and in female patients (multivariate Cox regression model, P < 0.02). Although rare, IP-CNS are important differential diagnoses among tumor-like intracranial lesions. Their potential risk of malignant transformation and high risk of recurrence necessitate close follow-up, especially when resection is incomplete. Prospective multicenter trials are needed to optimize classification and treatment of this rare inflammatory lesion. Copyright 2003, Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673560     DOI: 10.1053/hupa.2003.35

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  26 in total

1.  Dural lesions mimicking meningiomas: A pictorial essay.

Authors:  Danai Chourmouzi; Stamatia Potsi; Anestis Moumtzouoglou; Elisavet Papadopoulou; Kostas Drevelegas; Thomas Zaraboukas; Antonios Drevelegas
Journal:  World J Radiol       Date:  2012-03-28

2.  Unusual case of pancreatic inflammatory myofibroblastic tumor associated with spontaneous splenic rupture.

Authors:  Kamal S Hassan; Hector I Cohen; Fadi K Hassan; Shadi K Hassan
Journal:  World J Emerg Surg       Date:  2010-11-22       Impact factor: 5.469

3.  Inflammatory Pseudotumor in the Epidural Space of Lumbosacral Spine on (18)F-FDG PET/CT.

Authors:  Jin-Suk Kim; Shin Young Park
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

4.  Hemorrhagic intracranial inflammatory pseudotumor originating from the trigeminal nerve: a case report.

Authors:  Tae-Young Jung; Shin Jung; Min-Cheol Lee; Kyung-Sub Moon; In-Young Kim; Sam-Suk Kang; Soo-Han Kim
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

5.  A case of cutaneous inflammatory myofibroblastic tumor.

Authors:  Soo Bin Son; Young Soo Heo; Won Woong Shin; Tae Seok Oh; Hae Jun Song; Chil Hwan Oh
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

Review 6.  Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor.

Authors:  Lillian M Lai; M Beth McCarville; Patricia Kirby; Simon C S Kao; Toshio Moritani; Eve Clark; Kousei Ishigami; Armita Bahrami; Yutaka Sato
Journal:  Pediatr Radiol       Date:  2015-05-12

7.  Inflammatory myofibroblastic tumours of the respiratory system and the impact of the varying patterns.

Authors:  J V Lodhia; T D Christensen; S E Trotter; E S Bishay
Journal:  Ann R Coll Surg Engl       Date:  2016-01       Impact factor: 1.891

8.  The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.

Authors:  Giacomo Giulio Baldi; Mehdi Brahmi; Salvatore Lo Vullo; Elena Cojocaru; Olivier Mir; Michela Casanova; Bruno Vincenzi; Tommaso Martino De Pas; Giovanni Grignani; Maria Abbondanza Pantaleo; Jean Yves Blay; Robin Lewis Jones; Axel Le Cesne; Anna Maria Frezza; Alessandro Gronchi; Paola Collini; Angelo Paolo Dei Tos; Carlo Morosi; Luigi Mariani; Paolo Giovanni Casali; Silvia Stacchiotti
Journal:  Oncologist       Date:  2020-07-12

Review 9.  Inflammatory myofibroblastic tumor in the intradural extramedullary space of the lumbar spine with spondylolisthesis: case report and review of the literature.

Authors:  Sang Hoon Yoon; Ki-Jeong Kim; Sang Ki Chung; Hyun-Jib Kim; Gheeyoung Choe; Sang Bong Chung; Yong Jun Jin
Journal:  Eur Spine J       Date:  2009-11-26       Impact factor: 3.134

10.  Intracranial plasma cell granuloma.

Authors:  Dae-Jin Kim; Yu-Seok Choi; Young-Jin Song; Ki-Uk Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.